TRIVARX LTD - Announcements

0.00%

1.1¢

Market Cap $6.818M

Healthcare Biotechnology

TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology... TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

TRI	First Wellness Channel Partner commercial pilot commenses		16/02/16	427.57KB	Share
TRI	Partnership to evaluate wearable applications for Mental Hea	PRICE SENSITIVE	09/02/16	306.44KB	Share
TRI	Disclosure Document - S708A Notice		08/02/16	66.3KB	Share
TRI	Replacement Appendix 3B		08/02/16	257.69KB	Share
TRI	Replacement Appendix 3B		01/02/16	226.42KB	Share
TRI	Appendix 4C - quarterly	PRICE SENSITIVE	01/02/16	189.54KB	Share
TRI	Initial Director's Interest Notice		29/01/16	61.48KB	Share
TRI	Appendix 3B		29/01/16	158.61KB	Share
TRI	Highly distinguished US Medical expert appointed Director		27/01/16	373.86KB	Share
TRI	Receipt of R&D Tax Incentive Refund	PRICE SENSITIVE	14/01/16	89.85KB	Share
TRI	Agreement takes Medibio's stress diagnostic to Saudi Arabia		23/12/15	419.05KB	Share
TRI	MEB signs MOU with $100 billion NYSE listed medical company	PRICE SENSITIVE	22/12/15	322.36KB	Share
TRI	Results of Meeting		30/11/15	68.07KB	Share
TRI	Corporate Wellness Partner Program Commences		27/11/15	172.01KB	Share
TRI	Johns Hopkins University Depression Study Update	PRICE SENSITIVE	24/11/15	270.28KB	Share
TRI	Presentation to be given at ASX CEO Session today		17/11/15	1.39MB	Share
TRI	Foster Stockbroking Initiates Research Coverage on Medibio		11/11/15	268.68KB	Share
TRI	Medibio's corporate partner signs multinational customer	PRICE SENSITIVE	06/11/15	301.88KB	Share
TRI	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	199.98KB	Share
TRI	Notice of Annual General Meeting/Proxy Form		30/10/15	510.25KB	Share
TRI	Annual Report to shareholders		30/10/15	7.05MB	Share
TRI	Medebio collaborates with University of Ottawa on research	PRICE SENSITIVE	12/10/15	285.81KB	Share
TRI	Appendix 4G & Corporate Governance Statement		01/10/15	322.17KB	Share
TRI	Full Year Statutory Accounts		30/09/15	5.6MB	Share
TRI	Medibio signs second commercial agreement for Corporate Stre	PRICE SENSITIVE	25/09/15	403.34KB	Share
TRI	Disclosure Document - Notice under Section 708A (5)		08/09/15	64.19KB	Share
TRI	Appendix 3B		08/09/15	156.48KB	Share
TRI	Capital raising of $3.1 million to accelerate growth	PRICE SENSITIVE	02/09/15	95.3KB	Share
TRI	Investor Presentation		01/09/15	1.64MB	Share
TRI	Preliminary Final Report		01/09/15	417.59KB	Share
TRI	Trading Halt	PRICE SENSITIVE	31/08/15	209.37KB	Share
TRI	Medibio signs first commercial agreement for its Corporate S	PRICE SENSITIVE	27/08/15	400.82KB	Share
TRI	Trading Halt	PRICE SENSITIVE	25/08/15	211.76KB	Share
TRI	Trading Halt	PRICE SENSITIVE	25/08/15	211.82KB	Share
TRI	Medibio completes development of Corporate Stress Product		21/08/15	147.63KB	Share
TRI	Strong response from US Corporates and Universities	PRICE SENSITIVE	17/08/15	195.16KB	Share
TRI	June 2015 Quarter Operations report		04/08/15	98.05KB	Share
TRI	Appendix 4C - quarterly & Operations report	PRICE SENSITIVE	31/07/15	66KB	Share
TRI	Investor Presentation to be used in a series of US presentat		21/07/15	1.73MB	Share
TRI	Provisional Patent for improved objective diagnostic for dep	PRICE SENSITIVE	15/07/15	352.5KB	Share
TRI	Investor Update		10/07/15	7.65MB	Share
TRI	Disclosure Document - Notice under Section 708A		10/07/15	64.45KB	Share
TRI	Appendix 3B		10/07/15	154.69KB	Share
TRI	MEB lodges provisional patents covering stress breakthrough	PRICE SENSITIVE	02/07/15	148.21KB	Share
TRI	Ground-breaking test for the measurement of stress & impact		17/06/15	392.15KB	Share
TRI	Strategic Device Partnership	PRICE SENSITIVE	28/05/15	123.76KB	Share
TRI	Medibio Investor Presentation May 2015		20/05/15	1.09MB	Share
TRI	MEB processes first participant in Black Dog Institute	PRICE SENSITIVE	11/05/15	126.78KB	Share
TRI	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	172.97KB	Share
TRI	MEB acquires the US & Canadian Circadain Heart Rate patents	PRICE SENSITIVE	21/04/15	165.92KB	Share
TRI	Investor Presentation		20/04/15	3.09MB	Share
TRI	Eli Lilly Company Board member joins Medibio		14/04/15	137.44KB	Share
TRI	Appendix 3B		09/04/15	235.75KB	Share
TRI	Final Director's Interest Notice		08/04/15	62.02KB	Share
TRI	Change of Director's Interest Notice		08/04/15	75.07KB	Share
TRI	Change of Director's Interest Notice		08/04/15	130.5KB	Share
TRI	Change of Director's Interest Notice		08/04/15	70.07KB	Share
TRI	Initial Director's Interest Notice		08/04/15	61.1KB	Share
TRI	Board reorganisation		07/04/15	110.46KB	Share
TRI	Notice given under Section 708A (5) of the Corporations Act		07/04/15	68.52KB	Share
TRI	Appendix 3B		07/04/15	156.87KB	Share
TRI	Completion of $2.6 million capital raising		02/04/15	124.21KB	Share
TRI	Completion of Share Consolidation	PRICE SENSITIVE	20/03/15	79.67KB	Share
TRI	General Meeting Presentation		06/03/15	4.11MB	Share
TRI	Results of Meeting		06/03/15	165.67KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/15	3.5MB	Share
TRI	Investor Update		27/02/15	5.91MB	Share
TRI	Notice of General Meeting - ASX Waiver of LR10.13.3		13/02/15	86.14KB	Share
TRI	Commercialization Study confirm revenue opportunity	PRICE SENSITIVE	06/02/15	198.96KB	Share
TRI	Correction to Notice of Meeting Consolidation Timetable		03/02/15	84.44KB	Share
TRI	Notice of General Meeting/Proxy Form		03/02/15	1.89MB	Share
TRI	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	77.4KB	Share
TRI	Update on corporate reorganisation		29/01/15	87.44KB	Share
TRI	Investor Presentation		23/01/15	3.28MB	Share
TRI	Medibio Investor Presentation		09/12/14	3.27MB	Share
TRI	Medibio appoints US based CRO for its validation trials	PRICE SENSITIVE	05/12/14	164.15KB	Share
TRI	Reinstatement to Official Quotation	PRICE SENSITIVE	01/12/14	115.39KB	Share
TRI	Agreement with Johns Hopkins Hospital	PRICE SENSITIVE	01/12/14	146.07KB	Share
TRI	Results of Annual General Meeting		25/11/14	82.65KB	Share
TRI	Quarterly Cashflow Report	PRICE SENSITIVE	30/10/14	112.33KB	Share
TRI	Quarterly Activities Report	PRICE SENSITIVE	30/10/14	150.46KB	Share
TRI	Notice of Annual General Meeting/Proxy Form		22/10/14	347.45KB	Share
TRI	Annual Report 2014		24/09/14	368.57KB	Share
TRI	Rights Issue Shortfall Placed		19/09/14	278.15KB	Share
TRI	Appendix 3B		19/09/14	547.67KB	Share
TRI	Azul Tin Project Divestment	PRICE SENSITIVE	18/09/14	485.24KB	Share
TRI	Trading Halt Request		16/09/14	82.79KB	Share
TRI	Trading Halt	PRICE SENSITIVE	16/09/14	79.41KB	Share
TRI	Expiry of Unlisted Options		15/09/14	74.76KB	Share
TRI	Fertilizer Project Acquisition - Brazil	PRICE SENSITIVE	05/09/14	1.37MB	Share
TRI	708A Notice and Disclosure LR 3.10.5A		29/08/14	395.96KB	Share
TRI	Appendix 3B		29/08/14	493.9KB	Share
TRI	Acquisition of Brazilian Potash Project	PRICE SENSITIVE	28/08/14	991.76KB	Share
TRI	Trading Halt	PRICE SENSITIVE	27/08/14	233.58KB	Share
TRI	Ceasing to be a substantial holder x 2		21/08/14	129.72KB	Share
TRI	Change of Director's Interest Notice x 2		21/08/14	340.49KB	Share
TRI	Becoming a substantial holder		19/08/14	197.52KB	Share
TRI	Shareholder Update	PRICE SENSITIVE	19/08/14	247.24KB	Share
TRI	Appendix 3B		15/08/14	493.87KB	Share
TRI	Update on the Allotment of Shortfall Shares		15/08/14	313.4KB	Share

TRI First Wellness Channel Partner commercial pilot commenses
16/02/16		427.57KB	Share
TRI Partnership to evaluate wearable applications for Mental Hea
09/02/16	PRICE SENSITIVE	306.44KB	Share
TRI Disclosure Document - S708A Notice
08/02/16		66.3KB	Share
TRI Replacement Appendix 3B
08/02/16		257.69KB	Share
TRI Replacement Appendix 3B
01/02/16		226.42KB	Share
TRI Appendix 4C - quarterly
01/02/16	PRICE SENSITIVE	189.54KB	Share
TRI Initial Director's Interest Notice
29/01/16		61.48KB	Share
TRI Appendix 3B
29/01/16		158.61KB	Share
TRI Highly distinguished US Medical expert appointed Director
27/01/16		373.86KB	Share
TRI Receipt of R&D Tax Incentive Refund
14/01/16	PRICE SENSITIVE	89.85KB	Share
TRI Agreement takes Medibio's stress diagnostic to Saudi Arabia
23/12/15		419.05KB	Share
TRI MEB signs MOU with $100 billion NYSE listed medical company
22/12/15	PRICE SENSITIVE	322.36KB	Share
TRI Results of Meeting
30/11/15		68.07KB	Share
TRI Corporate Wellness Partner Program Commences
27/11/15		172.01KB	Share
TRI Johns Hopkins University Depression Study Update
24/11/15	PRICE SENSITIVE	270.28KB	Share
TRI Presentation to be given at ASX CEO Session today
17/11/15		1.39MB	Share
TRI Foster Stockbroking Initiates Research Coverage on Medibio
11/11/15		268.68KB	Share
TRI Medibio's corporate partner signs multinational customer
06/11/15	PRICE SENSITIVE	301.88KB	Share
TRI Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	199.98KB	Share
TRI Notice of Annual General Meeting/Proxy Form
30/10/15		510.25KB	Share
TRI Annual Report to shareholders
30/10/15		7.05MB	Share
TRI Medebio collaborates with University of Ottawa on research
12/10/15	PRICE SENSITIVE	285.81KB	Share
TRI Appendix 4G & Corporate Governance Statement
01/10/15		322.17KB	Share
TRI Full Year Statutory Accounts
30/09/15		5.6MB	Share
TRI Medibio signs second commercial agreement for Corporate Stre
25/09/15	PRICE SENSITIVE	403.34KB	Share
TRI Disclosure Document - Notice under Section 708A (5)
08/09/15		64.19KB	Share
TRI Appendix 3B
08/09/15		156.48KB	Share
TRI Capital raising of $3.1 million to accelerate growth
02/09/15	PRICE SENSITIVE	95.3KB	Share
TRI Investor Presentation
01/09/15		1.64MB	Share
TRI Preliminary Final Report
01/09/15		417.59KB	Share
TRI Trading Halt
31/08/15	PRICE SENSITIVE	209.37KB	Share
TRI Medibio signs first commercial agreement for its Corporate S
27/08/15	PRICE SENSITIVE	400.82KB	Share
TRI Trading Halt
25/08/15	PRICE SENSITIVE	211.76KB	Share
TRI Trading Halt
25/08/15	PRICE SENSITIVE	211.82KB	Share
TRI Medibio completes development of Corporate Stress Product
21/08/15		147.63KB	Share
TRI Strong response from US Corporates and Universities
17/08/15	PRICE SENSITIVE	195.16KB	Share
TRI June 2015 Quarter Operations report
04/08/15		98.05KB	Share
TRI Appendix 4C - quarterly & Operations report
31/07/15	PRICE SENSITIVE	66KB	Share
TRI Investor Presentation to be used in a series of US presentat
21/07/15		1.73MB	Share
TRI Provisional Patent for improved objective diagnostic for dep
15/07/15	PRICE SENSITIVE	352.5KB	Share
TRI Investor Update
10/07/15		7.65MB	Share
TRI Disclosure Document - Notice under Section 708A
10/07/15		64.45KB	Share
TRI Appendix 3B
10/07/15		154.69KB	Share
TRI MEB lodges provisional patents covering stress breakthrough
02/07/15	PRICE SENSITIVE	148.21KB	Share
TRI Ground-breaking test for the measurement of stress & impact
17/06/15		392.15KB	Share
TRI Strategic Device Partnership
28/05/15	PRICE SENSITIVE	123.76KB	Share
TRI Medibio Investor Presentation May 2015
20/05/15		1.09MB	Share
TRI MEB processes first participant in Black Dog Institute
11/05/15	PRICE SENSITIVE	126.78KB	Share
TRI Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	172.97KB	Share
TRI MEB acquires the US & Canadian Circadain Heart Rate patents
21/04/15	PRICE SENSITIVE	165.92KB	Share
TRI Investor Presentation
20/04/15		3.09MB	Share
TRI Eli Lilly Company Board member joins Medibio
14/04/15		137.44KB	Share
TRI Appendix 3B
09/04/15		235.75KB	Share
TRI Final Director's Interest Notice
08/04/15		62.02KB	Share
TRI Change of Director's Interest Notice
08/04/15		75.07KB	Share
TRI Change of Director's Interest Notice
08/04/15		130.5KB	Share
TRI Change of Director's Interest Notice
08/04/15		70.07KB	Share
TRI Initial Director's Interest Notice
08/04/15		61.1KB	Share
TRI Board reorganisation
07/04/15		110.46KB	Share
TRI Notice given under Section 708A (5) of the Corporations Act
07/04/15		68.52KB	Share
TRI Appendix 3B
07/04/15		156.87KB	Share
TRI Completion of $2.6 million capital raising
02/04/15		124.21KB	Share
TRI Completion of Share Consolidation
20/03/15	PRICE SENSITIVE	79.67KB	Share
TRI General Meeting Presentation
06/03/15		4.11MB	Share
TRI Results of Meeting
06/03/15		165.67KB	Share
TRI Half Yearly Report and Accounts
27/02/15	PRICE SENSITIVE	3.5MB	Share
TRI Investor Update
27/02/15		5.91MB	Share
TRI Notice of General Meeting - ASX Waiver of LR10.13.3
13/02/15		86.14KB	Share
TRI Commercialization Study confirm revenue opportunity
06/02/15	PRICE SENSITIVE	198.96KB	Share
TRI Correction to Notice of Meeting Consolidation Timetable
03/02/15		84.44KB	Share
TRI Notice of General Meeting/Proxy Form
03/02/15		1.89MB	Share
TRI Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	77.4KB	Share
TRI Update on corporate reorganisation
29/01/15		87.44KB	Share
TRI Investor Presentation
23/01/15		3.28MB	Share
TRI Medibio Investor Presentation
09/12/14		3.27MB	Share
TRI Medibio appoints US based CRO for its validation trials
05/12/14	PRICE SENSITIVE	164.15KB	Share
TRI Reinstatement to Official Quotation
01/12/14	PRICE SENSITIVE	115.39KB	Share
TRI Agreement with Johns Hopkins Hospital
01/12/14	PRICE SENSITIVE	146.07KB	Share
TRI Results of Annual General Meeting
25/11/14		82.65KB	Share
TRI Quarterly Cashflow Report
30/10/14	PRICE SENSITIVE	112.33KB	Share
TRI Quarterly Activities Report
30/10/14	PRICE SENSITIVE	150.46KB	Share
TRI Notice of Annual General Meeting/Proxy Form
22/10/14		347.45KB	Share
TRI Annual Report 2014
24/09/14		368.57KB	Share
TRI Rights Issue Shortfall Placed
19/09/14		278.15KB	Share
TRI Appendix 3B
19/09/14		547.67KB	Share
TRI Azul Tin Project Divestment
18/09/14	PRICE SENSITIVE	485.24KB	Share
TRI Trading Halt Request
16/09/14		82.79KB	Share
TRI Trading Halt
16/09/14	PRICE SENSITIVE	79.41KB	Share
TRI Expiry of Unlisted Options
15/09/14		74.76KB	Share
TRI Fertilizer Project Acquisition - Brazil
05/09/14	PRICE SENSITIVE	1.37MB	Share
TRI 708A Notice and Disclosure LR 3.10.5A
29/08/14		395.96KB	Share
TRI Appendix 3B
29/08/14		493.9KB	Share
TRI Acquisition of Brazilian Potash Project
28/08/14	PRICE SENSITIVE	991.76KB	Share
TRI Trading Halt
27/08/14	PRICE SENSITIVE	233.58KB	Share
TRI Ceasing to be a substantial holder x 2
21/08/14		129.72KB	Share
TRI Change of Director's Interest Notice x 2
21/08/14		340.49KB	Share
TRI Becoming a substantial holder
19/08/14		197.52KB	Share
TRI Shareholder Update
19/08/14	PRICE SENSITIVE	247.24KB	Share
TRI Appendix 3B
15/08/14		493.87KB	Share
TRI Update on the Allotment of Shortfall Shares
15/08/14		313.4KB	Share

REFRESH

First 5 6 7 8 9

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $6.818M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.1¢	$7.732K	701.4K

Buyers (Bids)

No.	Vol.	Price($)
7	3030000	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	760913	2

View Market Depth

No.	Vol.	Price($)
7	3030000	0.010
8	6886324	0.009
15	3470750	0.008
2	271571	0.007
2	385000	0.006

Price($)	Vol.	No.
0.012	760913	2
0.013	1017587	3
0.014	871302	4
0.015	1195000	4
0.016	1027142	2

Last trade - 13.06pm 16/09/2025 (20 minute delay)

TRI (ASX) Chart

TRIVARX LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available